1. PC3 - 151 Toca 5: A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined with Toca FC versus Standard of Care in Patients Undergoing Planned Resection for Recurrent Glioblastoma (GBM) or Anaplastic Astrocytoma (AA) (NCT02414165). (18th October 2016) Authors: Zadeh, G.; Bota, D.; Cachia, D.; Landolfi, J.; Schiff, D.; Vogelbaum, M.A.; Walbert, T.; Tran, D.; Chu, A.; Das, A.; Jolly, D.J.; Ibañez, C.E.; Ostertag, D.; Sully, S.; Cloughesy, T.F. Journal: Canadian journal of neurological sciences Issue: Volume 43(2016)Supplement 4 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗